CN101406511A - External-use medicament for treating vitiligo - Google Patents
External-use medicament for treating vitiligo Download PDFInfo
- Publication number
- CN101406511A CN101406511A CNA2008101604037A CN200810160403A CN101406511A CN 101406511 A CN101406511 A CN 101406511A CN A2008101604037 A CNA2008101604037 A CN A2008101604037A CN 200810160403 A CN200810160403 A CN 200810160403A CN 101406511 A CN101406511 A CN 101406511A
- Authority
- CN
- China
- Prior art keywords
- portions
- medicine
- treatment
- vitiligo
- healed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an external applied medicine for treating vitiligo. The formula for the medicine is prepared by the following medicine formula in portion by weight: 20 portions of malaytea scurfpea, 18 portions of semen astragali complanati caltrop, 18 portions of chaulmoogra, 18 portions of litharge, 10 portions of mercurous chloride, 18 portions of fructus cnidii and 6 portions of lopseed. The external applied medicine has the advantages that vitiligo is difficult to relapse after being healed, and the external applied medicine has no stimulant function; slight patients can be healed after 1 to 2 treatment periods, and heavy patients can be healed after 3 to 5 treatment periods; and the effective rate is 76 percent, and the cure rate is 62 percent.
Description
Technical field
The invention belongs to pure technical field of Chinese medicines, the leukodermic external used medicine of specifically a kind of treatment.
Background technology
Vitiligo has another name called vitiligo, and how evil objective in skin by rheumatism, consequently qi-blood disharmony, blood does not allow skin to form.The primary disease skin lesion appearing without definite location, for circumscribed skin pigment takes off mistake, but the white patch single-shot that skin clear-cut margin occurs, differs in size also can general, and hair bleaches in the speckle, smooth surface is superficial, sensation is normal, and its infringement can be at any position, but based on the exposure portion morbidity, the course of disease is slow, and utmost point refractory more.Doctor trained in Western medicine is used hormone medicine, chlormethine alcohol treatment more, and effect is undesirable, and cure rate is low, and zest is arranged, easily recurrence.The traditional Chinese medical science is then with psoralea tincture, vitiligo sheet treatment (wound science) Guangdong college of traditional Chinese medicine.Though certain curative effect is all arranged, its effect is all undesirable, and effective percentage is low, easily recurrence.
The invention reside in provides a kind of effective percentage height, cures the back and is difficult for recurrence, the leukodermic external used medicine of non-irritating a kind of treatment.
Summary of the invention
Theory of Chinese medical science thinks that vitiligo is how evil objective in skin by rheumatism, and consequently qi-blood disharmony, blood does not allow skin to form.The primary disease skin lesion appearing without definite location, for circumscribed skin pigment takes off mistake, but the white patch single-shot that skin clear-cut margin occurs, differs in size also can general, and hair bleaches in the speckle, smooth surface is superficial, sensation is normal, and its infringement can be at any position, but based on the exposure portion morbidity, the course of disease is slow, and utmost point refractory more.
The object of the invention provides a kind of effective percentage height, is difficult for recurrence, the leukodermic external used medicine of non-irritating a kind of treatment, Drug therapy vitiligo effective percentage 76% of the present invention, cure rate 62%.
Technical scheme of the present invention is achieved in that
Medicine of the present invention, the leukodermic external used medicine of a kind of treatment is characterized in that: it is made by following drugs and weight portion proportioning: Fructus Psoraleae 10-20, Semen Astragali Complanati 10-18, Semen Hydnocarpi 12-20, Lithargyrum 10-18, Calomelas 6-12, Fructus Cnidii 10-20, Herba speranskiae tuberculatae 6-9.
Medicine of the present invention, the leukodermic external used medicine of a kind of treatment is characterized in that: it is made by following drugs and weight portion proportioning: Fructus Psoraleae 20, Semen Astragali Complanati 18, Semen Hydnocarpi 18, Lithargyrum 18, Calomelas 10, Fructus Cnidii 18, Herba speranskiae tuberculatae 6.
Drug action mechanism of the present invention is as follows:
Fructus Psoraleae kidney invigorating and YANG supporting, modern pharmacological research have anti-photosensitization, and psoralen can promote the synthetic of dermal melanin, and makes it to be deposited on subcutaneous; Semen Astragali Complanati suppressing the hyperactive liver vegetables liver, dispelling pathogenic wind for improving eyesight, modern pharmacological research has immunity and anti-allergic effects, and dermatosis is had therapeutical effect preferably; Semen Hydnocarpi detoxicating and killing parasites, dispeiling pathogenic wind and removing dampness; Lithargyrum's removing dampness and killing parasites, detoxifcation, convergence, anticorrosion have the anti-dermatophyte effect; The Calomelas counteracting toxic substances, parasite killing; The Fructus Cnidii killing parasites for relieving itching, dispeiling pathogenic wind and removing dampness, warming the kidney to activate YANG has antifungic action; The Herba speranskiae tuberculatae expelling wind and removing dampness, promoting blood circulation and stopping pain.
The present invention dispels the wind with Fructus Psoraleae, Semen Astragali Complanati, strengthens the anti-allergic effects of skin; Lithargyrum, Calomelas, Semen Hydnocarpi, Fructus Cnidii dispeiling pathogenic wind and removing dampness, detoxicating and killing parasites; The Herba speranskiae tuberculatae priming is gone into skin, and all medicines are harmonious, mutually easily clear, have dispeiling pathogenic wind and removing dampness, the merit of detoxicating and killing parasites reaches the effect of rapid healing vitiligo.The processing of will adding medicine to cooks makes super cell grade (more than 300 orders) micropowder altogether, and it is standby to receive bottle.
1, using method: according to skin affected part size, get an amount of medicated powder,, smear, smear the 0.5-3 millimeters thick, changed a time medicine in per 2 days in the affected part with rice vinegar furnishing pasty state.
2, using the course of treatment: 3-15 days is a course of treatment, the lighter, and can cure 1-2 the course of treatment; Weight person, can cure 3-5 the course of treatment.
3, therapeutic effect: advantage of the present invention is to cure the back to be difficult for recurrence, has no stimulation.The lighter 1-2 can cure a course of treatment; Weight person, can cure 3-5 the course of treatment, effective percentage 76%, cure rate 62%.
4, taboo: hot, peppery, wine, cigarette.
The specific embodiment:
Embodiment: get Fructus Psoraleae 20, Semen Astragali Complanati 18, Semen Hydnocarpi 18, Lithargyrum 18, Calomelas 10, Fructus Cnidii 18, Herba speranskiae tuberculatae 6.The processing of will adding medicine to cooks makes super cell grade (more than 300 orders) micropowder altogether, and it is standby to receive bottle.
1, using method: according to skin affected part size, get an amount of medicated powder,, smear, smear the 0.5-3 millimeters thick, changed a time medicine in per 2 days in the affected part with rice vinegar furnishing pasty state.
2, using the course of treatment: 3-15 days is a course of treatment, the lighter, and can cure 1-2 the course of treatment; Weight person, can cure 3-5 the course of treatment.
3, therapeutic effect: advantage of the present invention is to cure the back to be difficult for recurrence, has no stimulation.The lighter 1-2 can cure a course of treatment; Weight person, can cure 3-5 the course of treatment, effective percentage 76%, cure rate 62%.
4, taboo: hot, peppery, wine, cigarette.
For showing the curative effect of medicine of the present invention, the 100 routine patients that treat are divided into test group and matched group, test group has Drug therapy of the present invention, and the matched group conventional therapy all is effectively with the sx, is recovery from illness with the transference cure.
Test group is treated 50 examples, effective percentage 76%, cure rate 62%.
Treatment of control group 50 examples, effective percentage 16%, cure rate 10%.
Claims (2)
1, the leukodermic external used medicine of a kind of treatment, it is characterized in that it is made by following drugs and weight portion proportioning: Fructus Psoraleae 10-20, Semen Astragali Complanati 10-18, Semen Hydnocarpi 12-20, Lithargyrum 10-18, Calomelas 6-12, Fructus Cnidii 10-20, Herba speranskiae tuberculatae 6-9.
2, the leukodermic external used medicine of a kind of treatment according to claim 1, it is characterized in that it is made by following drugs and weight portion proportioning: Fructus Psoraleae 20, Semen Astragali Complanati 18, Semen Hydnocarpi 18, Lithargyrum 18, Calomelas 10, Fructus Cnidii 18, Herba speranskiae tuberculatae 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101604037A CN101406511B (en) | 2008-11-18 | 2008-11-18 | External-use medicament for treating vitiligo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101604037A CN101406511B (en) | 2008-11-18 | 2008-11-18 | External-use medicament for treating vitiligo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101406511A true CN101406511A (en) | 2009-04-15 |
| CN101406511B CN101406511B (en) | 2010-11-17 |
Family
ID=40569856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101604037A Expired - Fee Related CN101406511B (en) | 2008-11-18 | 2008-11-18 | External-use medicament for treating vitiligo |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101406511B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012136930A2 (en) | 2011-04-05 | 2012-10-11 | Laboratoire Nuxe | Composition of chaulmoogra oil and tribulus terrestris for skin pigmentation |
| CN102908492A (en) * | 2012-10-24 | 2013-02-06 | 尹甲仑 | Traditional Chinese medicine composition for treating vitiligo and preparation method of traditional Chinese medicine composition |
| CN105833150A (en) * | 2016-05-17 | 2016-08-10 | 商皓 | Externally-applied medicine for treating leucoderma |
-
2008
- 2008-11-18 CN CN2008101604037A patent/CN101406511B/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012136930A2 (en) | 2011-04-05 | 2012-10-11 | Laboratoire Nuxe | Composition of chaulmoogra oil and tribulus terrestris for skin pigmentation |
| FR2973697A1 (en) * | 2011-04-05 | 2012-10-12 | Nuxe Lab | COMPOSITION BASED ON OIL OF CHAULMOOGRA AND TRIBULUS TERRESTRIS FOR THE PIGMENTATION OF THE SKIN. |
| WO2012136930A3 (en) * | 2011-04-05 | 2013-10-17 | Laboratoire Nuxe | Composition of chaulmoogra oil and tribulus terrestris for skin pigmentation |
| CN102908492A (en) * | 2012-10-24 | 2013-02-06 | 尹甲仑 | Traditional Chinese medicine composition for treating vitiligo and preparation method of traditional Chinese medicine composition |
| CN102908492B (en) * | 2012-10-24 | 2014-02-12 | 尹甲仑 | Traditional Chinese medicine composition for treating vitiligo and preparation method of traditional Chinese medicine composition |
| CN105833150A (en) * | 2016-05-17 | 2016-08-10 | 商皓 | Externally-applied medicine for treating leucoderma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101406511B (en) | 2010-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393916B (en) | External use ointment used for treating dermatitis and preparation method thereof | |
| CN101007139A (en) | An external applied medicine for treating burn and scald | |
| CN101406511B (en) | External-use medicament for treating vitiligo | |
| CN101007040B (en) | External applied medicine for treating bone fractures | |
| CN103977194A (en) | Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot | |
| CN101502577A (en) | Chinese medicinal external-use liquid for treating vitiligo and preparation method thereof | |
| CN100490865C (en) | Kidney-nourishing gout-treating capsule | |
| CN102462741A (en) | Sappan wood-pseudo-ginseng wine | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN108853301A (en) | A kind of Chinese medicine powder and preparation method thereof for superintending and directing moxibustion | |
| CN104096018A (en) | Traditional Chinese medicine composition for treating facial neural paralysis | |
| CN1228064C (en) | Externally appied medicine for relieving pain and diminishing inflammation | |
| CN104815029B (en) | A kind of drug and preparation method thereof for treating tinea pedis | |
| CN104083445B (en) | One treats leukodermic external application Chinese medicine | |
| CN202314968U (en) | Thermal moxibustion medication blanket | |
| CN107854551A (en) | A kind of burn pain-relieving paste formulation | |
| CN104027425B (en) | Medicine for external use of a kind of Acne treatment and preparation method thereof | |
| CN101940695B (en) | Chinese medicinal ointment for treating vitiligo and preparation method thereof | |
| CN106806445A (en) | A kind of Chinese medicine composition for treating leucoderma | |
| CN101579419B (en) | Medicinal liquor for treating hyperosteogeny | |
| CN101057915A (en) | Capsule for nourishing kidney and treating rheumatalgia | |
| CN1211118C (en) | Formula of medication for treating bone fracture and contuse | |
| CN1634228A (en) | Externally applied medicine for treating pertinacious headache | |
| CN101181435A (en) | Externally used medicament for curing acne | |
| Lu et al. | Chinese medicinal herb therapy for the rehabilitation of peripheral facial palsy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101117 Termination date: 20111118 |